top of page

BIOTECHNOLOGY

Biotechnology is developing new products by using living organisms. The sector has been driven by biopharmacy and tissue engineering / regeneration in recent years.

 

The organizations are concentrating on the enhancement of ingenious systems and their usage by partnering with members in the industry and funding programmes are assisting R&D in the sector. 


Biotechnology sector is expected to pass USD 800 billion by 2025.

CURRENT MOST COMMON APPLICATIONS OF BIOTECHNOLOGY

Fermentation
Tissue Engineering and Regeneration
PCR Technology
Nanobiotechnology
Chromatography
DNA Sequencing
Cell Based Assays

CURRENT MOST COMMON

SUBSEGMENTS OF BIOTECHNOLOGY

BioPharmacy
BioServices
BioAgriculture
BioIndustrial
Bioinformatics

STRATEGIC INNOVATION BASED GROWTH MODELS

ESTABLISHED COMPANIES

ameen-fahmy-ccvj2ZQaYaw-unsplash.jpg

New Market Development

osman-rana-dI9KhXi0ooE-unsplash.jpg

New Business Development

fuse-brussels-JI01fn0U7Cg-unsplash.jpg

Project

Development

joel-filipe-VuwAfoHpxgs-unsplash.jpg

New Business Creation

360 DEGREES VIEW FROM BUSINESS IDEA TO

SETTLEMENT IN THE ADDRESABLE MARKET

STARTUPS

stt.jpg

New Venture Creation

stt3.jpg

Funding

stt2.jpg

Commercialization

joel-filipe-76bu9sXOy_g-unsplash.jpg

International Market Presence

PAC  PROGRAM

denys-nevozhai-Jlx5n7jm1Pg-unsplash.jpg

Early-Stage & Late-Stage Startup Capital Providers

Checkbook Angels
Capital A Angels
Superangels
Venture Capital Firms

denys-nevozhai-pzqtRR_JSz0-unsplash.jpg

Generic Consultancy Firms & Design Thinking based Consultancy Firms 

Except of the cash cows in the sector, the key to sustain profitability is focusing in on the targeted persona

denys-nevozhai-k5w21D7PgMk-unsplash.jpg

Independent Advisors and Consultants 

Over 20 percent of the world's population is working independently. This figure is over 30 percent in the U.S.

bottom of page